OSI Pharmaceuticals Inc. (OSIP) reported fourth quarter net income from continuing operations of $0.90 per share after the close Tuesday, up from $0.62 in the prior year period. The consensus estimate was for EPS of $0.43.
February 25, 2010
No Comments »
No comments yet.
RSS feed for comments on this post.